Risk factors for osteoporosis in women - Risk assessment with ORAI and DEXA
DOI:
https://doi.org/10.32385/rpmgf.v21i6.10183Keywords:
Osteoporosis, Screening, Risk Factors, ORAIAbstract
Introduction: The Osteoporosis Risk Assessment Instrument (ORAI) is used as an method of evaluation of osteoporosis risk. Osteodensitometry by Double Energy X-ray Absorciometry (DEXA) evaluates bone mineral density. The universal screening of feminine osteoporosis using DEXA is not recommended. Currently, the individual risk assessment is considered the best way to select which patients should be submitted to DEXA. Aims: to describe osteoporosis risk in women above 45 years of age with ORAI, to analyse the association of risk and submission to DEXA and to assess risk factors of osteoporosis. Methods: Cross-sectional study in the Health Centre of Ermesinde, Valongo, Portugal. Population: women above 45 attending the Health Centre; random sample of 400 women. Study variables - osteoporosis risk, submission to DEXA, bone mineral density, age, weight, estrogens use, tobacco use, menopause, personal history of fractures, and family history of osteoporosis. Qui-square and exact Fishers tests were used. Adjusted Odds Ratios were calculated by logistic regression. The level of significance considered was 0,05. Results: 53,4% of women had high risk of osteoporosis and the proportion of women submitted to DEXA was 47,7%. However, no association was found between submission to DEXA and osteoporosis risk. Osteoporosis risk factors found in this study were age>64, early menopause and family history of osteoporosis. Discussion: There are doubts about the criteria used in the selection of patients submitted to DEXA. As in other studies, ORAI proved to be a good screening method for low bone mineral density. Other risk factors may as well be considered. The impossibility to analyse tobacco use in this context is one of the study limitations.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.